Jamshidiha Saeed, Rezaee Alireza, Hajati Farshid, Golzan Mojtaba, Chiong Raymond
Nanotechnology, Biotechnology, Information Technology and Cognitive Science Laboratory, University of Tehran, Tehran, Iran.
Department of Mechatronics, School of Intelligent Systems, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran.
Sci Rep. 2025 Jul 23;15(1):26773. doi: 10.1038/s41598-025-12498-2.
Alzheimer's disease (AD) is a neurodegenerative disorder that affects millions worldwide. In the absence of effective treatment options, early diagnosis is crucial for initiating management strategies to delay disease onset and slow down its progression. In this study, we propose Retformer, a novel transformer-based architecture for detecting AD using retinal imaging modalities, leveraging the power of transformers and explainable artificial intelligence. The Retformer model is trained on datasets of different modalities of retinal images from patients with AD and age-matched healthy controls, enabling it to learn complex patterns and relationships between image features and disease diagnosis. To provide insights into the decision-making process of our model, we employ the Gradient-weighted Class Activation Mapping algorithm to visualise the feature importance maps, highlighting the regions of the retinal images that contribute most significantly to the classification outcome. These findings are compared to existing clinical studies on detecting AD using retinal biomarkers, allowing us to identify the most important features for AD detection in each imaging modality. The Retformer model outperforms a variety of benchmark algorithms across different performance metrics by margins of up to 11%.
阿尔茨海默病(AD)是一种影响全球数百万人的神经退行性疾病。在缺乏有效治疗方案的情况下,早期诊断对于启动管理策略以延缓疾病发作并减缓其进展至关重要。在本研究中,我们提出了Retformer,这是一种基于新型Transformer架构的方法,用于利用视网膜成像模态检测AD,充分发挥Transformer和可解释人工智能的优势。Retformer模型在来自AD患者和年龄匹配的健康对照的不同模态视网膜图像数据集上进行训练,使其能够学习图像特征与疾病诊断之间的复杂模式和关系。为了深入了解我们模型的决策过程,我们采用梯度加权类激活映射算法来可视化特征重要性图,突出显示对分类结果贡献最大的视网膜图像区域。将这些发现与现有的使用视网膜生物标志物检测AD的临床研究进行比较,使我们能够确定每种成像模态中AD检测最重要的特征。Retformer模型在不同性能指标上比各种基准算法的表现高出多达11%。